Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture

April 2013

Past Event

Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture

Past Event

Washington, D.C. Area

April 08, 2013

April 2013

Past Event

1015 15th Street, N.W., 6th Floor
Washington, DC 20005

Speakers:

Dr. Scott Gottlieb

Resident Fellow, American Enterprise Institute; former deputy commissioner, FDA

Margaret Anderson

FasterCures

Joe Grogan

Gilead Sciences

Brian Harvey

Pfizer Inc.

Coleen Klasmeier

Sidley Austin LLP

Dan Leonard

National Pharmaceutical Council

Jennifer Luray

Michael Mandel

Progressive Policy Institute

Robert Popovian

Pfizer Inc.

Marc Tessier-Lavigne

Rockefeller University

Benjamin Zycher

American Enterprise Institute

On April 8, 2013, Hudson Institute’s Initiative on Future Innovation convened a distinguished panel of experts from business, science, public health, law, and the academic world for an off-the-record workshop on a working draft of Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture by Scott Gottlieb and Tevi Troy Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute, and formerly served as deputy commissioner of the Food and Drug Administration. Mr. Troy is a visiting fellow at Hudson Institute and former deputy secretary of the U.S. Department of Health and Human Services. Reclaiming Innovation in the Life Sciences — which will be published in final form as the fourth in a series of major research papers by Hudson’s Innovation Initiative, and thereafter available for download on this page — is a careful analysis of procedural rules and regulatory guidelines governing FDA review of proposed new medical treatments and pharmaceutical products, and a prescription for major reform of that system in the interests of improved public health and economic efficiency.

June 2026

Virtual Event | Hudson Institute

Authoritarian Persistence in Latin America: What Should the US Do?

Featured Speakers:

Elliot Abrams

Daniel Batlle

June 2026

Virtual Event | Hudson Institute

Authoritarian Persistence in Latin America: What Should the US Do?

Please join Adjunct Fellow Daniel Batlle for a conversation with Elliott Abrams, whose leadership on Latin America policy stretches from his service as assistant secretary of state for inter-American affairs under President Ronald Reagan to his role as special representative for Venezuela in the first Trump administration.

Featured Speakers:

Elliot Abrams

Daniel Batlle

Learn More

June 2026

In-Person Event | Hudson Institute

Spain’s Latin American Reckoning

Featured Speakers:

Julio Crespo MacLennan

Daniel Batlle

June 2026

In-Person Event | Hudson Institute

Spain’s Latin American Reckoning

Join Hudson as Adjunct Fellow Daniel Batlle sits down with Julio Crespo MacLennan, a historian and one of the leading scholars on Spain’s democratic transition and on Europe’s relationship with the wider world.

Featured Speakers:

Julio Crespo MacLennan

Daniel Batlle

Learn More

June 2026

In-Person Event | Hudson Institute

Growing the DIB: A Conversation with Deputy Assistant Secretary of War James Mismash

Featured Speakers:

Nadia Schadlow

James Mismash

June 2026

In-Person Event | Hudson Institute

Growing the DIB: A Conversation with Deputy Assistant Secretary of War James Mismash

Please join Hudson Institute for a fireside chat between Hudson Senior Fellow Nadia Schadlow and Deputy Assistant Secretary for Industrial Base Growth and Director of the Office of Small Business Programs James Mismash.

Featured Speakers:

Nadia Schadlow

James Mismash

Learn More

June 2026

In-Person Event | Hudson Institute

Winning the Innovation Competition

Featured Speakers:

Bryan Clark

Dan Patt

Emil Michael

June 2026

In-Person Event | Hudson Institute

Winning the Innovation Competition

Please join Hudson Institute Senior Fellows Bryan Clark and Dan Patt for a conversation with Under Secretary of War for Research and Engineering Emil Michael about the Department of War’s efforts to bring AI to the battlefield and implement an innovation strategy that makes the most of America’s commercial and government research sectors.